John J Gildea1. 1. Department of Pathology, University of Virginia, Charlottesville, Virginia, USA.
Abstract
PURPOSE OF REVIEW: To review the recent evidence demonstrating how the renal dopaminergic and angiotensin systems control renal electrolyte balance through various receptor-mediated pathways with counterregulatory interactions. RECENT FINDINGS: Stimulation of the renal rennin-angiotensin system results in increased sodium reabsorption, whereas the opposite is true for stimulation of the renal dopaminergic system. An underactive renal dopaminergic system has been associated with increased sodium reabsorption and hypertension. Recent findings indicate novel cell surface receptor-mediated mechanisms by which these two renal endocrine systems directly counterregulate each other. Each of the dopamine receptors (D1R through D5R) have been implicated in dopamine-mediated natriuresis, in addition to counterregulating the angiotensin type 1 R. Dopamine D1-like (D1R and D5R) stimulation has also been found to induce an AT2 receptor- dependent natriuresis. Recently, it has also been discovered that reactive oxygen species can play a role in inactivating the D1 receptor and activating the angiotensin type 1 R. SUMMARY: Current therapeutic interventions for hypertension predominantly involve correction of an overactive rennin-angiotensin aldosterone system. Recent evidence suggests that stimulation of the renal dopaminergic system and possibly activation of AT2 receptors, as well as decreasing reactive oxygen species, may provide additional therapeutic approaches.
PURPOSE OF REVIEW: To review the recent evidence demonstrating how the renal dopaminergic and angiotensin systems control renal electrolyte balance through various receptor-mediated pathways with counterregulatory interactions. RECENT FINDINGS: Stimulation of the renal rennin-angiotensin system results in increased sodium reabsorption, whereas the opposite is true for stimulation of the renal dopaminergic system. An underactive renal dopaminergic system has been associated with increased sodium reabsorption and hypertension. Recent findings indicate novel cell surface receptor-mediated mechanisms by which these two renal endocrine systems directly counterregulate each other. Each of the dopamine receptors (D1R through D5R) have been implicated in dopamine-mediated natriuresis, in addition to counterregulating the angiotensin type 1 R. Dopamine D1-like (D1R and D5R) stimulation has also been found to induce an AT2 receptor- dependent natriuresis. Recently, it has also been discovered that reactive oxygen species can play a role in inactivating the D1 receptor and activating the angiotensin type 1 R. SUMMARY: Current therapeutic interventions for hypertension predominantly involve correction of an overactive rennin-angiotensin aldosterone system. Recent evidence suggests that stimulation of the renal dopaminergic system and possibly activation of AT2 receptors, as well as decreasing reactive oxygen species, may provide additional therapeutic approaches.
Authors: Chunyu Zeng; Zheng Wang; Ulrich Hopfer; Laureano D Asico; Gilbert M Eisner; Robin A Felder; Pedro A Jose Journal: Hypertension Date: 2005-09-19 Impact factor: 10.190
Authors: Zhiwei Yang; Laureano D Asico; Peiying Yu; Zheng Wang; John E Jones; Crisanto S Escano; Xiaoyan Wang; Mark T Quinn; David R Sibley; Guillermo G Romero; Robin A Felder; Pedro A Jose Journal: Am J Physiol Regul Integr Comp Physiol Date: 2006-01 Impact factor: 3.619
Authors: Robin A Felder; Hironobu Sanada; Jing Xu; Pei-Ying Yu; Zheng Wang; Hidetsuna Watanabe; Laureano D Asico; Wei Wang; Shaopeng Zheng; Ikuyo Yamaguchi; Scott M Williams; James Gainer; Nancy J Brown; Debra Hazen-Martin; Lee-Jun C Wong; Jean E Robillard; Robert M Carey; Gilbert M Eisner; Pedro A Jose Journal: Proc Natl Acad Sci U S A Date: 2002-03-19 Impact factor: 11.205
Authors: Chunyu Zeng; Zhiwei Yang; Zheng Wang; John Jones; Xiaoyan Wang; Joanna Altea; Amy J Mangrum; Ulrich Hopfer; David R Sibley; Gilbert M Eisner; Robin A Felder; Pedro A Jose Journal: Hypertension Date: 2005-02-07 Impact factor: 10.190
Authors: Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng Journal: Hypertens Res Date: 2011-06-02 Impact factor: 3.872
Authors: Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia Journal: Mol Neurobiol Date: 2018-02-05 Impact factor: 5.590
Authors: Jannette Rodriguez-Pallares; Juan Andres Parga; Belen Joglar; Maria Jose Guerra; Jose Luis Labandeira-Garcia Journal: Age (Dordr) Date: 2011-06-29
Authors: Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra Journal: Am J Neurodegener Dis Date: 2012-11-18